BlueCrest Capital Management Ltd Buys Shares of 160,138 Arxis, Inc. $ARXS

BlueCrest Capital Management Ltd purchased a new position in shares of Arxis, Inc. (NASDAQ:ARXSFree Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 160,138 shares of the company’s stock, valued at approximately $7,389,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Alyeska Investment Group L.P. acquired a new stake in shares of Arxis in the 2nd quarter worth $13,842,000. Grandeur Peak Global Advisors LLC acquired a new position in Arxis during the 2nd quarter valued at about $2,740,000. IMC Chicago LLC purchased a new stake in Arxis in the second quarter valued at about $1,146,000. Amundi acquired a new stake in Arxis in the second quarter worth about $358,000. Finally, Squarepoint Ops LLC purchased a new stake in shares of Arxis during the second quarter worth about $19,506,000.

Analyst Upgrades and Downgrades

ARXS has been the subject of several research analyst reports. Citigroup increased their price objective on shares of Arxis from $61.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, August 13th. Weiss Ratings initiated coverage on shares of Arxis in a research report on Monday, August 3rd. They set a “sell (d+)” rating on the stock. Jefferies Financial Group reaffirmed a “buy” rating and issued a $60.00 price target on shares of Arxis in a report on Sunday, August 2nd. Wells Fargo & Company lifted their price objective on shares of Arxis from $52.00 to $63.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 4th. Finally, Morgan Stanley reissued an “overweight” rating and issued a $62.00 target price on shares of Arxis in a research report on Monday, August 3rd. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Arxis presently has an average rating of “Moderate Buy” and an average target price of $53.73.

Get Our Latest Stock Report on ARXS

Arxis Price Performance

Shares of Arxis stock opened at $52.43 on Thursday. The company has a current ratio of 5.21, a quick ratio of 3.79 and a debt-to-equity ratio of 0.38. The business’s fifty day simple moving average is $50.06. Arxis, Inc. has a 1 year low of $33.15 and a 1 year high of $61.50. The stock has a market capitalization of $21.89 billion and a PE ratio of 655.38.

Arxis (NASDAQ:ARXSGet Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.28 EPS for the quarter, beating the consensus estimate of ($0.07) by $0.35. The business had revenue of $500.73 million during the quarter. The business’s revenue for the quarter was up 25.0% compared to the same quarter last year. As a group, equities analysts expect that Arxis, Inc. will post 0.57 EPS for the current year.

Arxis Company Profile

(Free Report)

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers’ most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.

Featured Articles

Want to see what other hedge funds are holding ARXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arxis, Inc. (NASDAQ:ARXSFree Report).

Receive News & Ratings for Arxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arxis and related companies with MarketBeat.com's FREE daily email newsletter.